share_log

Ligand Pharmaceuticals | SC TO-C: Written communication relating to an issuer or third party tender offer

SEC ·  Aug 11, 2020 09:52
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.